Microbiota-derived short-chain fatty acids in hematopoietic stem cell transplantation: immunomodulation at the host-microbiota interface
Authors:
Top Cited Papers
Open Access
- 6 February 2026
- journal article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17
Abstract
Hematopoietic stem cell transplantation (HSCT) remains a cornerstone treatment for many hematological malignancies, but its clinical success is still challenged by graft-vs.-host disease (GvHD), infectious complications, and the profound microbial disruptions caused by conditioning, antibiotics, and hospitalization. Over the past few years, a growing body of work has highlighted how tightly post-transplant immunity is linked to the state of the gut microbiota. In particular, short-chain fatty acids (SCFAs), especially butyrate, have emerged as key microbial metabolites involved in maintaining epithelial barrier function, moderating inflammatory responses, and supporting regulatory T-cell homeostasis. In this review, we bring together current evidence on the SCFA-gut-immune axis in the setting of HSCT, with a focus on how transplant-related dysbiosis alters SCFA availability and contributes to immune imbalance. We also discuss the potential of strategies designed to restore or enhance SCFA production, ranging from dietary fiber interventions to next-generation probiotics and other microbiota-directed approaches. Overall, by better understanding and eventually harnessing the metabolic capacity of the gut microbiota, SCFA-centered therapies may offer new opportunities to support immune recovery, reduce GvHD risk, and improve outcomes for HSCT recipients. Still, well-designed clinical trials are needed to determine how these approaches can be safely and effectively integrated into transplant care.Keywords
This publication has 138 references indexed in Scilit:
- Inhibiting the CB1 receptor in CIH-induced animal model alleviates colon injuryApplied Microbiology and Biotechnology, 2024
- Correction to: The Human Gut Microbiota: A Dynamic Biologic Factory2024
- Butyrate’s (a short-chain fatty acid) microbial synthesis, absorption, and preventive roles against colorectal and lung cancerArchives of Microbiology, 2024
- Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host diseaseCancer Medicine, 2024
- Gut microbiota, intestinal permeability, and systemic inflammation: a narrative reviewInternal and Emergency Medicine, 2023
- Radioprotective potential of probiotics against gastrointestinal and neuronal toxicity: a preclinical studyClinical and Translational Oncology, 2023
- Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantationCancer and Metastasis Reviews, 2022
- The Gut Microbiome in Health and Disease2018
- 2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: Preface to the SeriesTransplantation and Cellular Therapy, 2015
- The Role of Short-Chain Fatty Acids in Health and Disease2014